The Evolving Regulatory Status of Cannabidiol

The Evolving Regulatory Status of Cannabidiol

On June 25, 2018, the U.S. Food and Drug Administration (FDA) announced its first-ever approval of a marijuana-derived pharmaceutical drug.

579
Like
Save

Comments

Comments are disabled for this post.

Malcare WordPress Security